Grafa News and Videos — Page 700

Kura Oncology (NASDAQ:KURA) reported 33%–50% response rates for darlifarnib plus cabozantinib among 34 evaluable advanced kidney-cancer patients.

Perfect Corp. (NYSE:PERF) reported second-quarter net income of $1.3 million, up 518.4%, while revenue remained stable at $16.3 million.

Legend Biotech (NASDAQ:LEGN) announced a significant leadership transition, confirming that Ying Huang, Ph.D., has stepped down from his role as Chief Executive Officer and as a member of the Board of Directors, effective July 24, 2026.

The Ensign Group (NASDAQ:ENSG) reported second-quarter revenue of $1.44 billion, up 17.3%, as occupancy and skilled-care revenue increased.

Rocket Lab (NASDAQ:RKLB) won a $266 million Space Force contract covering 12 suborbital vehicles and six optional launches.

IDEAYA Biosciences (NASDAQ:IDYA) announced the initiation of the Part 2 monotherapy expansion for its Phase 1/2 clinical trial evaluating IDE892.

AstraZeneca (NYSE:AZN) reported second-quarter core EPS of $2.63, up 21%, as oncology and rare-disease sales grew.

Japanese regulators are considering increasing the leverage limits available for cryptocurrency trading as part of a broader review of the country's digital asset rules.

US lawmakers are considering changes to the Clarity Act that would strengthen sanctions enforcement against illicit cryptocurrency activity linked to groups such as North Korea's Lazarus Group.

Spot Bitcoin (CRYPTO:BTC) exchange-traded funds have experienced renewed investor outflows, prompting closer scrutiny of the cryptocurrency's resilience amid changing liquidity conditions.